Skip to main content
. 2020 Mar 23;378(2):34. doi: 10.1007/s41061-020-0298-4

Fig. 9.

Fig. 9

Ligand selections for combinational modifications and some fused thiazolidine derivatives as HIV protease inhibitors 116(ad)